Literature DB >> 23162665

microRNA-195 suppresses osteosarcoma cell invasion and migration in vitro by targeting FASN.

Jian Hua Mao1, Rong Ping Zhou, Ai Fen Peng, Zhi Li Liu, Shan Hu Huang, Xin Hua Long, Yong Shu.   

Abstract

microRNAs are involved in different cancer-related processes. miR-195, one of the miR-16/15/195/424/497 family members, has been shown to act as a tumor suppressor during tumorigenesis. However, the function of miR-195 in osteosarcoma is still unclear. In our study, the miR-195 expression level was upregulated in osteosarcoma cells, by transfection with miR-195, and the fatty acid synthase (FASN) mRNA and protein expression levels were measured by RT-PCR and western blotting. Cell migration and invasion was measured using wound healing migration and Transwell invasion assays. We found that the upregulation of miR-195 greatly decreased cell invasion and the migration of U2OS. We also identified that FASN may be a direct target of miR-195 by the luciferase activity assay. These findings provide evidence that miR-195 plays a key role in inhibiting osteosarcoma cell migration and invasion through targeting FASN, and strongly suggest that exogenous miR-195 may have therapeutic value in treating osteosarcoma.

Entities:  

Year:  2012        PMID: 23162665      PMCID: PMC3499598          DOI: 10.3892/ol.2012.863

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  41 in total

1.  Genistein downregulates de novo lipid synthesis and impairs cell proliferation in human lung cancer cells.

Authors:  Daniel Hess; R Ariel Igal
Journal:  Exp Biol Med (Maywood)       Date:  2011-05-12

2.  Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease.

Authors:  Helen M Heneghan; Nicola Miller; Ronan Kelly; John Newell; Michael J Kerin
Journal:  Oncologist       Date:  2010-06-24

3.  Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

Authors:  Paul A Meyers; Cindy L Schwartz; Mark Krailo; Eugenie S Kleinerman; Donna Betcher; Mark L Bernstein; Ernest Conrad; William Ferguson; Mark Gebhardt; Allen M Goorin; Michael B Harris; John Healey; Andrew Huvos; Michael Link; Joseph Montebello; Helen Nadel; Michael Nieder; Judith Sato; Gene Siegal; Michael Weiner; Robert Wells; Lester Wold; Richard Womer; Holcombe Grier
Journal:  J Clin Oncol       Date:  2005-03-20       Impact factor: 44.544

4.  MicroRNAs as a potential prognostic factor in gastric cancer.

Authors:  Baruch Brenner; Moshe B Hoshen; Ofer Purim; Miriam Ben David; Karin Ashkenazi; Gideon Marshak; Yulia Kundel; Ronen Brenner; Sara Morgenstern; Marisa Halpern; Nitzan Rosenfeld; Ayelet Chajut; Yaron Niv; Michal Kushnir
Journal:  World J Gastroenterol       Date:  2011-09-21       Impact factor: 5.742

5.  Inhibition of fatty acid synthase in melanoma cells activates the intrinsic pathway of apoptosis.

Authors:  Karina G Zecchin; Franco A Rossato; Helena F Raposo; Daniela R Melo; Luciane C Alberici; Helena C F Oliveira; Roger F Castilho; Ricardo D Coletta; Aníbal E Vercesi; Edgard Graner
Journal:  Lab Invest       Date:  2010-08-30       Impact factor: 5.662

6.  Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.

Authors:  Xueqing Wang; Jiandong Wang; Henghui Ma; Jin Zhang; Xiaojun Zhou
Journal:  Med Oncol       Date:  2011-03-10       Impact factor: 3.064

7.  MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells.

Authors:  Teng Xu; Ying Zhu; Yujuan Xiong; Yi-Yuan Ge; Jing-Ping Yun; Shi-Mei Zhuang
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

8.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

9.  Serum fatty acid synthase as a marker of pancreatic neoplasia.

Authors:  Kim Walter; Seung-Mo Hong; Sinead Nyhan; Marcia Canto; Neal Fedarko; Alison Klein; Margaret Griffith; Noriyuki Omura; Susan Medghalchi; Frank Kuhajda; Michael Goggins
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-09-01       Impact factor: 4.254

10.  Long-term survivals of stage IIb osteosarcoma: a 20-year experience in a single institution.

Authors:  Yool Cho; Gu-Hee Jung; So-Hak Chung; Ji-Yeon Kim; Young Choi; Jae-Do Kim
Journal:  Clin Orthop Surg       Date:  2011-02-15
View more
  38 in total

1.  MicroRNA-126 inhibits osteosarcoma cells proliferation by targeting Sirt1.

Authors:  Jian-Qiang Xu; Ping Liu; Ming-Jue Si; Xiao-Yi Ding
Journal:  Tumour Biol       Date:  2013-07-24

Review 2.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

3.  The microRNAs miR-449a and miR-424 suppress osteosarcoma by targeting cyclin A2 expression.

Authors:  Ritu Shekhar; Priyanka Priyanka; Praveen Kumar; Tanushree Ghosh; Md Muntaz Khan; Perumal Nagarajan; Sandeep Saxena
Journal:  J Biol Chem       Date:  2019-01-24       Impact factor: 5.157

4.  microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma.

Authors:  Niuniu Sun; Lin Ye; Tingmin Chang; Xiaojing Li; Xiumin Li
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

5.  MicroRNA-320 inhibits osteosarcoma cells proliferation by directly targeting fatty acid synthase.

Authors:  Chi Cheng; Zhen-Qiang Chen; Xue-Tao Shi
Journal:  Tumour Biol       Date:  2014-01-05

6.  Downregulation of microRNA-497 is associated with upregulation of synuclein γ in patients with osteosarcoma.

Authors:  Liang Wang; Hongwei Gao; Ningji Gong; Mingzhi Gong
Journal:  Exp Ther Med       Date:  2016-10-26       Impact factor: 2.447

7.  Biological roles of microRNA-140 in tumor growth, migration, and metastasis of osteosarcoma in vivo and in vitro.

Authors:  Rui Gu; Yi-Fu Sun; Min-Fei Wu; Jia-Bei Liu; Jin-Lan Jiang; Shuai-Hua Wang; Xin-Lei Wang; Qiang Guo
Journal:  Tumour Biol       Date:  2015-07-29

8.  miR-124 Acts as a Tumor Suppressor in Glioblastoma via the Inhibition of Signal Transducer and Activator of Transcription 3.

Authors:  Weihao Li; Hui Huang; Junhua Su; Xin Ji; Xiaobin Zhang; Zhiping Zhang; Hong Wang
Journal:  Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.590

9.  Metformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193b.

Authors:  Reema S Wahdan-Alaswad; Dawn R Cochrane; Nicole S Spoelstra; Erin N Howe; Susan M Edgerton; Steven M Anderson; Ann D Thor; Jennifer K Richer
Journal:  Horm Cancer       Date:  2014-09-12       Impact factor: 3.869

10.  Differential expression of miRNAs with metabolic implications in hibernating thirteen-lined ground squirrels, Ictidomys tridecemlineatus.

Authors:  Daneck Lang-Ouellette; Pier Morin
Journal:  Mol Cell Biochem       Date:  2014-05-30       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.